|
Market Closed -
Nasdaq Stockholm
12:30:00 30/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 7.750 SEK | +1.84% |
|
+7.34% | -42.59% |
| 10-20 | 15 stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange | FW |
| 10-13 | Vivesto to present positive study data for Paccal Vet at veterinary congress | FW |
Company Valuation: Vivesto AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,176 | 233.5 | 219.3 | 156 | 72.64 | 84.25 | - | - |
| Change | - | -80.14% | -6.11% | -28.83% | -53.45% | 15.99% | - | - |
| Enterprise Value (EV) 1 | 1,176 | 91 | 219.3 | 123.7 | 70.54 | 76.25 | 67.25 | 45.25 |
| Change | - | -92.26% | 140.94% | -43.56% | -43% | 8.1% | -11.8% | -32.71% |
| P/E | -8.74x | -1.28x | -1.7x | -4.14x | -2.25x | -2.53x | -2.1x | -1.58x |
| PBR | 2.13x | 0.45x | - | 0.99x | 0.58x | 0.59x | 0.56x | 0.49x |
| PEG | - | -0.1x | 0.1x | 0.1x | 0.2x | 0.1x | -0.1x | -0x |
| Capitalization / Revenue | 44.9x | 230x | - | - | - | - | - | - |
| EV / Revenue | 44.9x | 89.7x | - | - | - | - | - | - |
| EV / EBITDA | -11.8x | -1.01x | - | -3.34x | -2.16x | -2.54x | -1.72x | -0.87x |
| EV / EBIT | -9.14x | -0.55x | - | -2.95x | -2.05x | -2.46x | -1.68x | -0.85x |
| EV / FCF | -43.7x | -0.72x | - | -32.2x | -2.08x | -2.54x | -1.68x | -0.85x |
| FCF Yield | -2.29% | -138% | - | -3.11% | -48.1% | -39.3% | -59.5% | -117% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -30 | -34 | -24 | -7 | -6 | -3.01 | -3.62 | -4.82 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 26.19 | 1.015 | - | - | - | - | - | - |
| EBITDA 1 | -99.77 | -90.53 | - | -37.05 | -32.58 | -30 | -39 | -52 |
| EBIT 1 | -128.6 | -165 | - | -41.96 | -34.38 | -31 | -40 | -53 |
| Net income 1 | -132.7 | -166.7 | -128.7 | -39.75 | -0.006 | -31 | -40 | -53 |
| Net Debt 1 | - | -142.5 | - | -32.29 | -2.098 | -8 | -17 | -39 |
| Reference price 2 | 262.300 | 43.400 | 40.750 | 29.000 | 13.500 | 7.610 | 7.610 | 7.610 |
| Nbr of stocks (in thousands) | 4,484 | 5,380 | 5,380 | 5,380 | 5,380 | 11,071 | - | - |
| Announcement Date | 24/02/22 | 23/02/23 | 23/04/24 | 20/02/25 | 01/03/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.53x | - | -2.54x | - | 8.55M | |
| 40.35x | 13.85x | 30.26x | 0.5% | 1,224B | |
| 40.28x | 6.76x | 19.02x | 1.94% | 662B | |
| 38.08x | 8.51x | 17.61x | 2.36% | 514B | |
| 21.65x | 5.25x | 13.07x | 2.49% | 388B | |
| 106.67x | 5.95x | 25.48x | 2.33% | 361B | |
| 22.86x | 5.89x | 14.22x | 2.75% | 302B | |
| 22.82x | 4.6x | 13.15x | 1.92% | 271B | |
| 29.23x | 7.45x | 13.34x | 2.19% | 249B | |
| -47.64x | 7.37x | 28.55x | 1.99% | 205B | |
| Average | 27.18x | 7.29x | 17.22x | 2.05% | 417.69B | |
| Weighted average by Cap. | 36.66x | 8.71x | 21.55x | 1.73% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- VIVE Stock
- Valuation Vivesto AB
Select your edition
All financial news and data tailored to specific country editions
